Brian Berger
Retina Specialist · Austin, TXNPI 1649257312
Payments from drug & device makers
Across 1,136 payments — averaging $6760.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$4.1M
- Roche TCRC, Inc.$2.4M
- AstraZeneca$466K
- Boehringer Ingelheim$184K
- Boehringer Ingelheim International GmbH$132K
- Eyepoint US, Inc.$124K
- plus $247K from 15 others
Across 2 payments — averaging $2123.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$4K
What the payments were for
- Consulting fees$11,68633%
- Speaking & faculty fees$6,88219%
- Travel & lodging$12,53135%
- Food & beverage$4,48913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 538 | $4,131,499 |
| Roche TCRC, Inc. | 392 | $2,395,061 |
| AstraZeneca | 7 | $466,250 |
| Boehringer Ingelheim | 19 | $184,207 |
| Boehringer Ingelheim International GmbH | 12 | $132,388 |
| Eyepoint US, Inc. | 5 | $124,124 |
| Janssen Research & Development, LLC | 25 | $73,538 |
| Kyowa Kirin, Inc. | 24 | $58,849 |
| Ocular Therapeutix, Inc. | 16 | $48,245 |
| Regeneron | 11 | $39,626 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 50 | $13,384 |
| Novo Nordisk AS | 4 | $4,577 |
| Novartis | 20 | $4,352 |
| F. Hoffmann-la Roche AG | 3 | $3,731 |
| Heidelberg Engineering, Inc. | 1 | $184 |
| Optos, Inc. | 2 | $182 |
| Biotissue Holdings Inc. | 1 | $124 |
| Astellas Pharma Global Development | 2 | $49 |
| AbbVie(2 entities) | 2 | $40 |
| Genentech USA, Inc. | 1 | $21 |
| Spark Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Covered Product$8,443
- BEOVU$569
- Lucentis$270
- Spectralis$184
- EYLEA HD$150
- SUSVIMO$146
- VABYSMO$146
- YUTIQ$145
- Prokera$124
- AmnioGraft$124
How this compares
$7,680,443 in reported general payments places this provider in the 95th percentile of 108 retina specialist providers in Texas.
Other retina specialist in Austin
- Cecilia SanchezAustin$893K
- Isaac LooseAustin$167K
- Richard LaneSan Antonio$4.7M
- Emmanuel ChangBellaire$3.7M
- Jeremiah BrownSchertz$3M
- Victor GonzalezMcAllen$2.1M
- Courtney CrawfordBurleson$1.2M
- Sarah HolySan Antonio$689K
- Lindsey HarrisHouston$592K
- Timothy ClelandSan Antonio$534K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.